Investing

Neumora Therapeutics : NMRA

NMRA

Stock Data

$2.44

$0.03 (1.21%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Neumora Therapeutics Inc is a pioneering biopharmaceutical company focused on creating innovative treatments for brain-related conditions. With a robust pipeline, including a leading drug candidate in phase 3 trials for major depressive disorder and several others targeting a range of disorders from Alzheimer’s agitation to schizophrenia and Parkinson’s disease, Neumora is at the forefront of addressing complex neuropsychiatric and neurodegenerative diseases. Founded in 2019 and based in Watertown, Massachusetts, the company is dedicated to improving the lives of patients with groundbreaking science.